Expression of HA of HPAI H5N1 virus at US2 gene insertion site of Turkey Herpesvirus induced better protection than that at US10 gene insertion site

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Gao, Hongbo ^a   Cui, Hongyu ^a,b   Cui, Xianlan ^c   Shi, Xingming ^a   Zhao, Yan ^a   Zhao, Xiaoyan ^a   Quan, Yanming ^a   Yan, Shuai ^a   Zeng, Weiwei ^a   Wang, Yunfeng ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b HEBEI NORTH UNIVERSITY   (China)

^c Department of Primary Industries   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HERPES VACCINE; HERPESVIRUS VECTOR; RECOMBINANT VACCINE; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; AVIAN INFLUENZA VIRUS; CELL GROWTH; CELL KINETICS; CONTROLLED STUDY; DRUG EFFICACY; EMBRYO; EMBRYO CELL; FIBROBLAST CULTURE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE INSERTION; GENE LOCUS; GENE TARGETING; HAEMAGGLUTININ GENE; HEMAGGLUTINATION INHIBITION TEST; INFECTION PREVENTION; INFLUENZA A (H5N1); INFLUENZA VIRUS A H5N1; MAREK DISEASE; NONHUMAN; PLAQUE FORMING CELL; PROVOCATION TEST; TURKEY (REPUBLIC); UNIQUE SHORT 10 GENE; UNIQUE SHORT 2 GENE; VIRAL GENE DELIVERY SYSTEM; VIREMIA; VIRUS GENE; VIRUS RECOMBINANT; ANIMAL; AVIAN INFLUENZA; CHICK EMBRYO; CHICKEN; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC RECOMBINATION; GENETICS; HEMAGGLUTINATION TEST; IMMUNOLOGY; MARDIVIRUS; METABOLISM; SOUTHERN BLOTTING; TREATMENT OUTCOME; VIROLOGY; WESTERN BLOTTING;

ANIMALIA; AVIAN INFLUENZA VIRUS; GALLID HERPESVIRUS 2; GALLUS GALLUS; MELEAGRID HERPESVIRUS 1;

ANIMALS; BLOTTING, SOUTHERN; BLOTTING, WESTERN; CHICK EMBRYO; CHICKENS; FLUORESCENT ANTIBODY TECHNIQUE; GENES, VIRAL; HEMAGGLUTINATION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HERPESVIRUS 1, MELEAGRID; HERPESVIRUS 2, GALLID; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; MUTAGENESIS, INSERTIONAL; RECOMBINATION, GENETIC; TREATMENT OUTCOME; VIREMIA;

EID: 79960810600     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022549     Document Type: Article

References (41)

1. Baigent SJ, Petherbridge LJ, Smith LP, Zhao Y, Chesters PM, et al. (2006) Herpesvirus of turkey reconstituted from bacterial artificial chromosome clones induces protection against Marek's disease. J Gen Virol 87: 769-776.
2. Calnek BW, Witter RL, eds. (1991) Marek's disease, 9th ed Iowa Iowa State University Press.
3. Fauqet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA, eds. (2005) Virus Taxonomy, VIIIth Report of the ICTV London Elsevier.
4. Okazaki W, Purchase HG, Burmester BR, (1970) Protection against Marek's disease by vaccination with a herpesvirus of turkeys. Avian Dis 14: 413-429.
5. Purchase HG, Okazaki W, Burmester BR, (1972) Long-term field trials with the herpesvirus of turkeys vaccine against Marek's disease. Avian Dis 16: 57-71.
6. Witter RL, (1998) Control strategies for Marek's disease: a perspective for the future. Poult Sci 77: 1197-1203.
7. Reddy SK, Sharma JM, Ahmad J, Reddy DN, McMillen JK, et al. (1996) Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek's diseases in specific-pathogen-free chickens. Vaccine 14: 469-477.
8. Witter RL, Nazerian K, Purchase HG, Burgoyne GH, (1970) Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus. Am J Vet Res 31: 525-538.
9. Darteil R, Bublot M, Laplace E, Bouquet JF, Audonnet JC, et al. (1995) Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens. Virology 211: 481-490.
10. Morgan RW, Gelb J Jr, Schreurs CS, Lutticken D, Rosenberger JK, et al. (1992) Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein. Avian Dis 36: 858-870.
11. Morgan RW, Gelb J Jr, Pope CR, Sondermeijer PJ, (1993) Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: onset of protection and effect of maternal antibodies. Avian Dis 37: 1032-1040.
12. Bacon LD, Witter RL, (1992) Influence of turkey herpesvirus vaccination on the B-haplotype effect on Marek's disease resistance in 15.B-congenic chickens. Avian Dis 36: 378-385.
13. Rauw F, Gardin Y, Palya V, Anbari S, Lemaire S, et al. (2010) Improved vaccination against Newcastle disease by an in ovo recombinant HVT-ND combined with an adjuvanted live vaccine at day-old. Vaccine 28: 823-833.
14. Ross LJ, Binns MM, Tyers P, Pastorek J, Zelnik V, et al. (1993) Construction and properties of a turkey herpesvirus recombinant expressing the Marek's disease virus homologue of glycoprotein B of herpes simplex virus. J Gen Virol 74 (Pt 3): 371-377.
15. Zelnik V, Tyers P, Smith GD, Liang C, Ross NL, (1995) Structure and properties of a herpesvirus of turkeys recombinant in which US1, US10 and SORF3 genes have been replaced by a lacZ expression cassette. J Gen Virol 76 (Pt 11): 2903-2907.
16. Tsukamoto K, Kojima C, Komori Y, Tanimura N, Mase M, et al. (1999) Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2. Virology 257: 352-362.
17. Sakaguchi M, Nakamura H, Sonoda K, Okamura H, Yokogawa K, et al. (1998) Protection of chickens with or without maternal antibodies against both Marek's and Newcastle diseases by one-time vaccination with recombinant vaccine of Marek's disease virus type 1. Vaccine 16: 472-479.
18. Cantello JL, Anderson AS, Francesconi A, Morgan RW, (1991) Isolation of a Marek's disease virus (MDV) recombinant containing the lacZ gene of Escherichia coli stably inserted within the MDV US2 gene. J Virol 65: 1584-1588.
19. Parcells MS, Anderson AS, Cantello JL, Morgan RW, (1994) Characterization of Marek's disease virus insertion and deletion mutants that lack US1 (ICP22 homolog), US10, and/or US2 and neighboring short-component open reading frames. J Virol 68: 8239-8253.
20. Alexander DJ, (2000) A review of avian influenza in different bird species. Vet Microbiol 74: 3-13.
21. Nayak B, Rout SN, Kumar S, Khalil MS, Fouda MM, et al. (2009) Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses. PLoS One 4: e6509.
22. Veits J, Wiesner D, Fuchs W, Hoffmann B, Granzow H, et al. (2006) Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proc Natl Acad Sci U S A 103: 8197-8202.
23. Veits J, Romer-Oberdorfer A, Helferich D, Durban M, Suezer Y, et al. (2008) Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions. Vaccine 26: 1688-96.
24. Schroer D, Veits J, Grund C, Dauber M, Keil G, et al. (2009) Vaccination with Newcastle disease virus vectored vaccine protects chickens against highly pathogenic H7 avian influenza virus. Avian Dis 53: 190-197.
25. Webster RG, Kawaoka Y, Taylor J, Weinberg R, Paoletti E, (1991) Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens. Vaccine 9: 303-308.
26. Gage PJ, Levine M, Glorioso JC, (1993) Syncytium-inducing mutations localize to two discrete regions within the cytoplasmic domain of herpes simplex virus type 1 glycoprotein B. J Virol 67: 2191-2201.
27. Purchase HG, Burmester BR, Cunningham CH, (1971) Pathogenicity and Antigenicity of Clones from Strains of Marek's Disease Virus and the Herpesvirus of Turkeys. Infect Immun 3: 295-303.
28. Chen SJ, Sun L, Liu WJ, Sun XH, Liu XF, (2006) [Recombinant fowlpox virus coexpressing HA and NA gene from subtype H5N1 of avian influenza virus and its protective efficacy]. Wei Sheng Wu Xue Bao 46: 111-114.
29. Cheng J, Liu X, Pen D, Liu H, (2002) [Recombinant fowlpox virus expressing HA from subtype H9N2 of avian influenza virus and its protective immunity against homologous challenge in chickens]. Wei Sheng Wu Xue Bao 42: 442-447.
30. Ge J, Deng G, Wen Z, Tian G, Wang Y, et al. (2007) Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J Virol 81: 150-158.
31. Mingxiao M, Ningyi J, Zhenguo W, Ruilin W, Dongliang F, et al. (2006) Construction and immunogenicity of recombinant fowlpox vaccines coexpressing HA of AIV H5N1 and chicken IL18. Vaccine 24: 4304-4311.
32. Xia CY, Guan YT, Nan X, Yu WT, Chen HY, (2000) Test of virulent Marek's disease virus Jing-1 strain infection in BWEL-SPF chicks. Chinese J Vet Sci Tech 30: 24-25.
33. Liu AL, Liu CJ, Zhang YP, Li JM, Shi WS, et al. (2009) Mutational analysis of Meq, RLORF4, RLORF12 and 132bpr genes of epidemic Marek's disease virus strains highly passaged on chicken embryo fibroblast. Bing Du Xue Bao 25: 368-375.
34. Shi WS, Liu CJ, Zhang YP, Qin YA, Zhang XW, et al. (2008) Cloning and sequence analysis of the Meq gene of 4 Marek's disease virus isolates from China. Bing Du Xue Bao 24: 117-125.
35. Cui S, Tong G, (2008) A chromatographic strip test for rapid detection of one lineage of the H5 subtype of highly pathogenic avian influenza. J Vet Diagn Invest 20: 567-571.
36. Liu CN, Liu M, Zhang Y, Liu CG, Gao XL, (2006) Pathogenicity of H5N1 Influenza Virus for Ducks. Scientia Agricultura Sinica 39: 412-417.
37. Kozak M, (1987) At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J Mol Biol 196: 947-950.
38. Lan D, Shi X, Wang Y, Cui H, Liu C, et al. (2008) [Reconstituting turkey herpesvirus with bacterial artificial chromosome clones]. Wei Sheng Wu Xue Bao 48: 811-817.
39. Cui HY, Wang YF, Shi XM, An TQ, Tong GZ, et al. (2009) Construction of an infectious Marek's disease virus bacterial artificial chromosome and characterization of protection induced in chickens. J Virol Methods 156: 66-72.
40. Sambrook J, Fritsch EF, Maniatis T, eds. (1989) Molecular cloning: a laboratory manual. 2nd ed Cold Spring Harbor, NY Cold Spring Harbor Laboratory Press.
41. Lee LF, Lupiani B, Silva RF, Kung HJ, Reddy SM, (2008) Recombinant Marek's disease virus (MDV) lacking the Meq oncogene confers protection against challenge with a very virulent plus strain of MDV. Vaccine 26: 1887-1892.